Nantahala Capital Management, LLC 13D and 13G filings for Cue Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-02 5:21 pm Sale | 2022-12-01 | 13G | Cue Biopharma, Inc. CUE | Nantahala Capital Management, LLC | 93,297 0.300% | -2,446,403 (-96.33%) | Filing |
| 2022-02-14 08:09 am Purchase | 2021-12-31 | 13G | Cue Biopharma, Inc. CUE | Nantahala Capital Management, LLC | 2,539,700 8.000% | 32,928 (+1.31%) | Filing |
| 2021-02-12 3:19 pm Purchase | 2020-12-31 | 13G | Cue Biopharma, Inc. CUE | Nantahala Capital Management, LLC | 2,506,772 8.300% | 1,101,831 (+78.43%) | Filing |